Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil

Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)

NCT00915044 ·Status: UNKNOWN

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

NCT03090139 ·Status: COMPLETED

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

NCT02229344 ·Status: COMPLETED

Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease

NCT07181525 ·Status: RECRUITING

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03662542 ·Status: COMPLETED ·Phase: PHASE2

Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

NCT03359642 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

NCT05377580 ·Status: COMPLETED ·Phase: PHASE2

A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

NCT05626088 ·Status: ACTIVE_NOT_RECRUITING

IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE

NCT03809728 ·Status: RECRUITING ·Phase: NA

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

NCT04873700 ·Status: COMPLETED

Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

NCT05153850 ·Status: UNKNOWN

Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF

NCT01605188 ·Status: COMPLETED

Pathogenic Study of Adult Immune Enteropathies

NCT04280510 ·Status: RECRUITING

Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

NCT02054533 ·Status: COMPLETED

Inflammatory Bowel Disease Research Registry

NCT00574028 ·Status: COMPLETED

Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk

NCT02193464 ·Status: RECRUITING

Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease

NCT02861118 ·Status: COMPLETED

Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis

NCT03235752 ·Status: COMPLETED ·Phase: PHASE2

Prognosis in UC After First Biological

NCT05530122 ·Status: COMPLETED

Multi-omics to Predict Responses to Biologics in IBD

NCT05542459 ·Status: UNKNOWN

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

NCT02791854 ·Status: ENROLLING_BY_INVITATION

Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives

NCT01140802 ·Status: TERMINATED

Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis

NCT03808506 ·Status: WITHDRAWN

IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study

NCT06165029 ·Status: RECRUITING